Literature DB >> 16020772

Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10.

Rae A Kokotailo1, Michael D Hill.   

Abstract

BACKGROUND AND
PURPOSE: Surveillance is necessary to understand and meet the future demands stroke will place on health care. Administrative data are the most accessible data source for stroke surveillance in Canada. The International Classification of Diseases, 10th revision (ICD-10) coding system has potential improvements over ICD-9 for stroke classification. Our purpose was to compare hospital discharge abstract coding using ICD-9 and ICD-10 for stroke and its risk factors.
METHODS: We took advantage of a switch in coding systems from ICD-9 to ICD-10 to independently review stroke patient charts. From time periods April 2000 to March 2001, 717 charts, and from April 2002 to March 2003, 249 charts were randomly selected for review. Using a before-and-after time period design, the accuracy of hospital coding of stroke (part I) and stroke risk factors (part II) using ICD-9 and ICD-10 was compared. We used careful definitions of stroke and its types based on ICD-9 using the fourth and fifth digit modifier codes.
RESULTS: Stroke coding was equally good with ICD-9 (90% [CI95 86 to 93] correct) and ICD-10 [92% (CI95 88 to 95 correct) with ICD-10. There were some differences in coding by stroke type, notably with transient ischemic attack, but these differences were not statistically significant. Atrial fibrillation, coronary artery disease/ischemic heart disease, diabetes mellitus, and hypertension were coded with high sensitivity (81% to 91%) and specificity (83% to 100%). ICD-10 was as good as ICD-9 for stroke risk factor coding.
CONCLUSIONS: Passive surveillance using administrative data are a useful tool for identifying stroke and its risk factors using both ICD-9 and ICD-10.

Entities:  

Mesh:

Year:  2005        PMID: 16020772     DOI: 10.1161/01.STR.0000174293.17959.a1

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  220 in total

1.  Deaths from stroke in US young adults, 1989-2009.

Authors:  Sharon N Poisson; David Glidden; S Claiborne Johnston; Heather J Fullerton
Journal:  Neurology       Date:  2014-10-31       Impact factor: 9.910

2.  Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Authors:  Wolfgang C Winkelmayer; Jun Liu; Soko Setoguchi; Niteesh K Choudhry
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

3.  Incidence and Determinants of Traumatic Intracranial Bleeding Among Older Veterans Receiving Warfarin for Atrial Fibrillation.

Authors:  John A Dodson; Andrew Petrone; David R Gagnon; Mary E Tinetti; Harlan M Krumholz; J Michael Gaziano
Journal:  JAMA Cardiol       Date:  2016-04-01       Impact factor: 14.676

4.  Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.

Authors:  Paul Muntner; Lisandro D Colantonio; Mary Cushman; David C Goff; George Howard; Virginia J Howard; Brett Kissela; Emily B Levitan; Donald M Lloyd-Jones; Monika M Safford
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

5.  Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.

Authors:  Jingwen Tan; Sunjae Bae; Jodi B Segal; Junya Zhu; G Caleb Alexander; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Nephrology (Carlton)       Date:  2019-02       Impact factor: 2.506

6.  Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.

Authors:  Benjamin A Goldstein; Cristina M Arce; Mark A Hlatky; Mintu Turakhia; Soko Setoguchi; Wolfgang C Winkelmayer
Journal:  Circulation       Date:  2012-10-02       Impact factor: 29.690

7.  Direct oral anticoagulant and antiplatelet combination therapy: Hemorrhagic events in coronary artery stent recipients.

Authors:  Kimon Bekelis; Chiang-Hua Chang; David Malenka; Nancy E Morden
Journal:  J Clin Neurosci       Date:  2018-02-01       Impact factor: 1.961

8.  Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.

Authors:  Sylvie Perreault; Payman Shahabi; Robert Côté; Stéphanie Dumas; Étienne Rouleau-Mailloux; Yassamin Feroz Zada; Sylvie Provost; Ian Mongrain; Marc Dorais; Thao Huynh; Simon Kouz; Ariel Diaz; Mark Blostein; Simon de Denus; Jacques Turgeon; Jeffrey Ginsberg; Jacques Lelorier; Lyne Lalonde; Lambert Busque; Jeannine Kassis; Mario Talajic; Jean-Claude Tardif; Marie-Pierre Dubé
Journal:  Clin Cardiol       Date:  2018-05-15       Impact factor: 2.882

9.  Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies.

Authors:  Anatoli I Yashin; Svetlana V Ukraintseva; Igor V Akushevich; Konstantin G Arbeev; Alexander Kulminski; Lucy Akushevich
Journal:  Mech Ageing Dev       Date:  2008-03-25       Impact factor: 5.432

10.  Understanding the reasons behind the low utilisation of thrombolysis in stroke.

Authors:  Ashraf Eissa; Ines Krass; Christopher Levi; Jonathan Sturm; Rabsima Ibrahim; Beata Bajorek
Journal:  Australas Med J       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.